Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)
Clinical trial NCT04891770 · COMPLETED
Trial details
- NCT number
- NCT04891770
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-14
- Primary completion
- 2024-01-23
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.